Skip to main content

Drugs: Licensing

Question for Department of Health

UIN 70390, tabled on 13 April 2017

To ask the Secretary of State for Health, what assessment his Department has made of the potential effect of NICE and NHS England's proposed changes to the arrangements for evaluating and funding drugs and other health technologies appraised through NICE's technology appraisal and highly specialised technologies programme on NICE's forecasted Technology Appraisal publication timeframes.

Answered on

24 April 2017

Wherever possible, the National Institute for Health and Care Excellence (NICE) will continue to aim to publish draft guidance on new drugs and significant license extensions for existing drugs appraised within six months of the product receiving its marketing authorisation in the United Kingdom.

The fast track technology appraisal process will reduce the timeframe for development of technology appraisal guidance on eligible drugs by around three months and NHS England will fund drugs recommended through the fast track process one month after publication, bringing forward patient access by around five months.

Answered by

Department of Health and Social Care